688000-41-1 Usage
Uses
Used in Pharmaceutical Industry:
TETRAHYDRO-FURAN-2-CARBOXAMIDINE HOAC is used as a building block for the production of pharmaceuticals, contributing to the development of new drugs and improving existing ones.
Used in Agrochemical Industry:
TETRAHYDRO-FURAN-2-CARBOXAMIDINE HOAC is used as a building block for the production of agrochemicals, aiding in the creation of more effective and environmentally friendly products.
Used in Fine Chemicals Production:
TETRAHYDRO-FURAN-2-CARBOXAMIDINE HOAC is used as a building block for the production of other fine chemicals, enhancing the quality and variety of specialty chemicals available.
Used in Catalytic Processes:
TETRAHYDRO-FURAN-2-CARBOXAMIDINE HOAC is used in catalytic processes due to its ability to form stable complexes with metals, improving the efficiency and effectiveness of various chemical reactions.
Used in Drug Intermediates Preparation:
TETRAHYDRO-FURAN-2-CARBOXAMIDINE HOAC is used in the preparation of intermediates for the production of drugs and other organic compounds, making it an essential component in the chemical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 688000-41-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,8,0,0 and 0 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 688000-41:
(8*6)+(7*8)+(6*8)+(5*0)+(4*0)+(3*0)+(2*4)+(1*1)=161
161 % 10 = 1
So 688000-41-1 is a valid CAS Registry Number.
688000-41-1Relevant academic research and scientific papers
Macrocyclic MCL-1 inhibitors and methods of use
-
Paragraph 0918, (2019/02/28)
The present disclosure provides for compounds of Formula (I) wherein A2, A3, A4, A6, A7, A8, A15, RA, R5, R9, R10A, R10B, R11, R12, R13, R14, R16, W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).
